Pharmaceutical Market Research Report

Psoriasis Biosimilars Market Size, Share & Trends Analysis Report By Drug Class (TNF-alpha inhibitors (Infliximab, Etanercept, Adalimumab), Other biosimilars), By Route of Administration (Subcutaneous, Intravenous, Oral, Topical), By Indication (Plaque psoriasis, Psoriatic arthritis, Other types), By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2891 | Published : 2024-11-13 | Pages: 160 | Format: PDF/EXCEL

Psoriasis Biosimilars Market Size is valued at USD 8.5 billion in 2023 and is predicted to reach USD 19.3 billion by the year 2031 at a 10.9% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Type (ATTR-PN, ATTR-CM), By Therapy (Targeted Therapy (Onpattro, Inotersen, Vyndaqel/Vyndamax), Supportive Therapy, Pipeline Therapy), By Disease Type (Hereditary Transthyretin Amyloidosis (Polyneuropathy, Cardiomyopathy, Mixed Type), Wild Type Amyloidosis), By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2890 | Published : 2024-11-12 | Pages: 165 | Format: PDF/EXCEL

Transthyretin Amyloidosis Treatment Market Size is valued at USD 5.2 billion in 2023 and is predicted to reach USD 9.4 billion by the year 2031 at a 7.90% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Immune-Mediated Inflammatory Diseases Market Size, Share & Trends Analysis Report By Treatment Type (Traditional Drugs, Biologic Therapies, Novel Therapies), Indication (Asthma, Chronic Obstructive Pulmonary Diseases (COPD), Inflammatory Bowel Disease (IBD), Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Psoriasis, Others), By Route of Administration, End-Users, Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2889 | Published : 2024-11-12 | Pages: 165 | Format: PDF/EXCEL

Immune-Mediated Inflammatory Diseases Market Size is estimated to grow at a 7.10% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

RNA-Targeted Small Molecules Market Size, Share & Trends Analysis Report By Product & Service (mRNA translation regulation, Indirect RNA targeting-epitranscriptomics, RNA Splicing Modification, Direct RNA Targeting), By Application (Drug discovery, Oncology research, Disease identification), By End-User, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2887 | Published : 2024-11-12 | Pages: 165 | Format: PDF/EXCEL

RNA-Targeted Small Molecules Market Size is valued at USD 2.24 billion in 2023 and is predicted to reach USD 3.60 billion by the year 2031 at a 6.29% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Idiopathic Pulmonary Fibrosis Management Market Size, Share & Trends Analysis Report By Drug Class (Pirfenidone, Nintedanib, Interferon Gammato1b, Others), By Treatment (Oxygen Therapy, Lung Transplant), By Route of Administration, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region, And By Segment Forecasts, 2024-2031

Report ID : 2885 | Published : 2024-11-12 | Pages: 165 | Format: PDF/EXCEL

Idiopathic Pulmonary Fibrosis Management Market Size is valued at USD 3,113.5 Mn in 2023 and is predicted to reach USD 3,429.6 Mn by the year 2031 at a 1.28% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Mitochondrial-Based Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Indication, By Route of Administration, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2884 | Published : 2024-11-12 | Pages: 172 | Format: PDF/EXCEL

Mitochondrial-Based Therapeutics Market Size is valued at USD 388.2 Mn in 2023 and is predicted to reach USD 682.7 Mn by the year 2031 at a 7.5% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size, Share & Trends Analysis Report By Drug Types (Lepirudin, Danaparoid, Argatroban), By Test Types (Enzyme Immunoassay (EIA), Serotonin Release Assay (SRA), Enzyme-Linked Immunosorbent Assay (ELISA), Heparin-Induced Platelet Activation (HIPA) Test), By End User, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2877 | Published : 2024-11-08 | Pages: 165 | Format: PDF/EXCEL

Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size is valued at USD 9.38 billion in 2023 and is predicted to reach USD 13.55 billion by the year 2031 at a 4.81% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Fibrotic Diseases Treatment Market Size, Share & Trends Analysis Report By Treatment (Medication, Organ Transplantation, Oxygen Therapy, and Others), Application (Idiopathic Pulmonary Fibrosis, Hepatic Cirrhosis, Renal Fibrosis, Cutaneous Fibrosis, and Others), End User, Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

Report ID : 2876 | Published : 2024-11-07 | Pages: 165 | Format: PDF/EXCEL

Fibrotic Diseases Treatment Market Size is valued at USD 3.57 billion in 2023 and is predicted to reach USD 5.40 billion by the year 2031 at a 5.53% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users, And Distribution Channels, Region And Segment Forecasts, 2024-2031

Report ID : 2874 | Published : 2024-11-07 | Pages: 168 | Format: PDF/EXCEL

Celiac Disease Market Size is valued at USD 581.6 Mn in 2023 and is predicted to reach USD 1,195.5 Mn by the year 2031 at a 9.8% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Oral Proteins and Peptides Market Share & Trends Analysis Report, By Type of Target Disease Indication (Acromegaly, Celiac Disease, Chronic Idiopathic Constipation, Enteric Hyperoxaluria, Inflammatory Bowel Disease, and Type II Diabetes), Type of Molecule (Protein and Peptide), Type of Biological Target, Type of Mechanism of Action, By Region, and Segment Forecasts, 2024-2031

Report ID : 2868 | Published : 2024-11-05 | Pages: 170 | Format: PDF/EXCEL

Oral Proteins and Peptides Market Size is valued at USD 6.51 Bn in 2023 and is predicted to reach USD 28.17 Bn by the year 2031 at an 20.3% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Molecular Cytogenetics Market Size, Share & Trends Analysis Distribution by Product (Kits & Reagents, Instruments, Consumables, Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Chromogenic In-Situ Hybridization, Other Techniques), Application, End User and Segment Forecasts, 2024-2031

Report ID : 2863 | Published : 2024-10-28 | Pages: 172 | Format: PDF/EXCEL

Molecular Cytogenetics Market Size is valued at USD 3.13 Bn in 2023 and is predicted to reach USD 6.72 Bn by the year 2031 at an 10.4% CAGR during the forecast period for 2024-2031. ... Read More >>

View Sample PDF

Non-muscle Invasive Bladder Cancer Market Size, Share & Trends Analysis Report By Treatment Type (Immunotherapy, Chemotherapy, Targeted Therapy), By Cancer Type (Low Grade Bladder Cancer, High Grade Bladder Cancer), By End-user (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031

Report ID : 2859 | Published : 2024-10-17 | Pages: 170 | Format: PDF/EXCEL

Non-muscle Invasive Bladder Cancer Market Size is valued at USD 2.7 billion in 2023 and is predicted to reach USD 10.9 billion by the year 2031 at a 19.2% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Age-related Macular Degeneration (AMD) Drugs Market Size, Share & Trends Analysis Distribution by Products (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre, Other Products), Molecules (Ranibizumab, Aflibercept, Faricimab, Pegcetoplan, Other Molecules), Type of AMD (Wet AMD, Dry AMD), Approval type (Biologic, Biosimilar) End User and Segment Forecasts, 2024-2031

Report ID : 2854 | Published : 2024-10-15 | Pages: 172 | Format: PDF/EXCEL

Age-related Macular Degeneration (AMD) Drugs Market Size is valued at USD 9.58 Bn in 2023 and is predicted to reach USD 19.77 Bn by the year 2031 at an 9.7% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report, By Product Type (Conventional NPWT Devices, Disposable NPWT Devices, NPWT Accessories), By Wound Type (Burns and Surgical Open Wounds, Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Traumatic Wound), By End User (Home Care Settings, Hospitals, Others), By Region, Forecasts, 2024-2031

Report ID : 2838 | Published : 2024-10-09 | Pages: 167 | Format: PDF/EXCEL

Negative Pressure Wound Therapy Market Size was valued at USD 2.47 Bn in 2023 and is predicted to reach USD 4.11 Bn by 2031 at a 6.8% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

The Retinoic Acid Pathway Therapeutics Market Size, Share & Trends Analysis Distribution by Product Type (Retinoic Acid Receptor Agonists (RAR Agonists), Retinoid X Receptor Agonists (RXR Agonists), RAR and RXR Dual Agonists, Others (Novel/Next-Generation Retinoic Acid Derivatives)), Application, Route of Administration, Distribution Channel, End-user and Segment Forecasts, 2024-2031

Report ID : 2816 | Published : 2024-10-07 | Pages: 170 | Format: PDF/EXCEL

Retinoic Acid Pathway Therapeutics Market Size is predicted to grow at an 7.4% CAGR during the forecast period for 2024-2031. ... Read More >>

$ 4456

View Sample PDF

Pharmaceuticals

468 Pharmaceuticals Reseach Report Available

$ 4456

$ 4456

$ 4456

$ 4456

$ 4456

Mitochondrial-Based Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Indication, By Route of Administration, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

$ 4456

$ 4456

$ 4456

Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users, And Distribution Channels, Region And Segment Forecasts, 2024-2031

$ 4456

$ 4456

$ 4456

$ 4456

$ 4456

$ 4456

Categories

Press Release